MCKESSON CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 531.1 USD | -1.14% |
|
-0.81% | +14.71% |
| Apr. 30 | Citigroup Adjusts Price Target on McKesson to $620 From $575 | MT |
| Apr. 24 | McKesson Keeps Quarterly Dividend at $0.62 Per Share; Payable July 1 to Shareholders of Record on June 3 | MT |
ETFs positioned on McKesson Corporation
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 117 M€ | -0.14% | - | |
| 0.01% | 6 M€ | -4.26% | - | |
| 0.00% | 11 M€ | +0.24% | - | |
| 0.01% | 34 M€ | +1.32% | - | |
| 4.84% | 121 M€ | +2.98% | - |
McKesson Corporation specializes in pharmaceutical product distribution. The group also offers technological services to healthcare companies. Net sales break down by activity as follows:
- distribution of pharmaceutical products (87%);
- distribution of medical and surgical products (4%);
- other (1.6%): primarily technology services and software sales.
The remaining net sales (7.4%) are from international activities.
Sector
Pharmaceuticals
Calendar
2024-05-07
- Q4 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
531.1
USD
Average target price
562.2
USD
Spread / Average Target
+5.85%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +14.71% | 70.59B | |
| +1.36% | 25.06B | |
| +7.11% | 8.2B | |
| -20.55% | 7.96B | |
| -2.98% | 7.92B | |
| +3.91% | 4.71B | |
| +17.12% | 4.32B | |
| -1.24% | 4.01B | |
| -3.44% | 3.82B | |
| +21.42% | 3.62B |
- Stock Market
- Equities
- MCK Stock
- Funds and ETFs McKesson Corporation
